Brain cancer diagnosis and therapy with nanoplatforms

被引:237
作者
Koo, Yong-Eun Lee
Reddy, G. Ramachandra
Bhojani, Mahaveer
Schneider, Randy
Philbert, Martin A.
Rehemtulla, Alnawaz
Ross, Brian D.
Kopelman, Raoul [1 ]
机构
[1] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
[2] Mol Therapeut Inc, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Environm Sci, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA
关键词
nanoparticles; blood-brain barrier; drug delivery; MRI; chemotherapy; photodynamic therapy; targeting;
D O I
10.1016/j.addr.2006.09.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Treatment of brain cancer remains a challenge despite recent improvements in surgery and multimodal adjuvant therapy. Drug therapies of brain cancer have been particularly inefficient, due to the blood-brain barrier and the non-specificity of the potentially toxic drugs. The nanoparticle has emerged as a potential vector for brain delivery, able to overcome the problems of current strategies. Moreover, multi-functionality can be engineered into a single nanoplatform so that it can provide tumor-specific detection, treatment, and follow-up monitoring. Such multitasking is not possible with conventional technologies. This review describes recent advances in nanoparticle-based detection and therapy of brain cancer. The advantages of nanoparticle-based delivery and the types of nanoparticle systems under investigation are described, as well as their applications. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1556 / 1577
页数:22
相关论文
共 126 条
[41]   Noninvasive detection of clinically occult lymph-node metastases in prostate cancer [J].
Harisinghani, MG ;
Barentsz, J ;
Hahn, PF ;
Deserno, WM ;
Tabatabaei, S ;
van de Kaa, CH ;
de la Rosette, J ;
Weissleder, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25) :2491-U5
[42]  
Harrell JA, 2000, BIOPHOTONICS INT, V7, P22
[43]  
Haubner R, 2001, CANCER RES, V61, P1781
[44]   Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs [J].
Izquierdo, MA ;
Scheffer, GL ;
Flens, MJ ;
Shoemaker, RH ;
Rome, LH ;
Scheper, RJ .
CYTOTECHNOLOGY, 1996, 19 (03) :191-197
[45]   Polysaccharide colloidal particles as delivery systems for macromolecules [J].
Janes, KA ;
Calvo, P ;
Alonso, MJ .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :83-97
[46]   ADJUVANT HIGH-DOSE PHOTORADIATION THERAPY IN THE TREATMENT OF CEREBRAL GLIOMA - A PHASE 1-2 STUDY [J].
KAYE, AH ;
MORSTYN, G ;
BROWNBILL, D .
JOURNAL OF NEUROSURGERY, 1987, 67 (04) :500-505
[47]  
KING D J, 1989, Reviews on Environmental Health, V8, P3
[48]   Development of a hydroxyl radical ratiometric nanoprobe [J].
King, M ;
Kopelman, R .
SENSORS AND ACTUATORS B-CHEMICAL, 2003, 90 (1-3) :76-81
[49]  
Kircher MF, 2003, CANCER RES, V63, P8122
[50]   Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer [J].
Kopelman, R ;
Koo, YEL ;
Philbert, M ;
Moffat, BA ;
Reddy, GR ;
McConville, P ;
Hall, DE ;
Chenevert, TL ;
Bhojani, MS ;
Buck, SM ;
Rehemtulla, A ;
Ross, BD .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2005, 293 (01) :404-410